Reported results
- Net loss for the quarter ended September 30, 2026, was $12.9 million compared to a net loss of $9.0 million for the quarter ended September 30, 2025.
- Net loss per basic and diluted share was $(0.26) for the quarter ended September 30, 2026, compared to $(0.22) for the quarter ended September 30, 2025.
- Total expenses for the quarter ended September 30, 2026, were $14.5 million compared to $9.8 million for the quarter ended September 30, 2025.
- Research and development expenses were $8.6 million for the quarter ended September 30, 2026, compared to $3.4 million for the quarter ended September 30, 2025.
- General and administrative expenses were $5.9 million for the quarter ended September 30, 2026, compared to $6.4 million for the quarter ended September 30, 2025.
- As of September 30, 2026, the Company had $176.5 million in cash and cash equivalents.
Guidance
- BB-301 pivotal study design to be finalized in the first calendar quarter of 2027.
- The company remains on track to begin the BB-301 pivotal trial in mid-2027.
Notes
Benitec plans to change its fiscal year-end for financial reporting from June 30 to December 31 commencing with its first periodic report following the Form 10-Q for the fiscal quarter ended September 30, 2026.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-13 (8-K, Item 2.02). Read the original filing on sec.gov.
